On August 28, 2025 CorMedix Inc. ("CorMedix") (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, reported that senior management will be presenting and participating in investor meetings at upcoming investor conferences taking place in September (Press release, CorMedix, AUG 28, 2025, View Source [SID1234655545]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cantor Global Healthcare Conference
Date: September 5, 2025
Time: 8:35am Eastern
Format: Fireside Chat
Webcast: Link to webcast
Morgan Stanley 23rd Annual Global Healthcare Conference
Date: September 10, 2025
Time: 10:45am Eastern
Format: Fireside Chat
Webcast: Link to webcast